The North America nucleic acid amplification testing market reached USD 4.91 billion in 2026. This growth is driven by rising demand for point-of-care diagnostics and advances in genomic technologies. Deepa Pandey, Senior Research Analyst, curated this report based on several trends. Her report benefits biotechnology firms, biopharmaceutical companies, diagnostic laboratories, CROs and CDMOs, specialized service providers, and technology enablers.